Skip to search formSkip to main content

ALX-0081

Known as: ALX 0081, ALX0681, ALX0081 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

caplacizumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Balancing Scattering Channels: A Panoscopic Approach toward Zero Temperature Coefficient of Resistance Using High-Entropy Alloys.
Designing alloys with an accurate temperature-independent electrical response over a wide temperature range, specifically a low… Expand
Is this relevant?
2017
2017
Composite Electrolyte for All-Solid-State Lithium Batteries: Low-Temperature Fabrication and Conductivity Enhancement.
All-solid-state lithium batteries offer notable advantages over conventional Li-ion batteries with liquid electrolytes in terms… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura.
ALX-0681 is a therapeutic Nanobody targeting the A1-domain of VWF. It inhibits the interaction between ultra-large VWF and… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2012
2012
Self mass attenuation coefficients for mixture of some 3 d elements Ni 100x Alx and Zn 100x – Alx at Am-241 ( 40 mCi )
In this paper we study the mass attenuation coefficients (μm) for Ni100-x Alx, Zn100xAlx ) mixtures with different weight ratios… Expand
  • figure 1
  • figure 4
  • figure 2
  • figure 5
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs.
Neutralizing the interaction of the platelet receptor gpIb with VWF is an attractive strategy to treat and prevent thrombotic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention.
Compound ALX-0081 is a bivalent humanised Nanobody® that binds the A1-domain of von Willebrand factor (VWF) with high affinity… Expand
Is this relevant?
Review
2010
Review
2010
Targeting von Willebrand factor and platelet glycoprotein Ib receptor.
Atherothrombotic events, such as acute coronary syndrome or stroke, are the result of platelet activation. Von Willebrand factor… Expand
  • figure 1
Is this relevant?
2009
2009
Microstructure and Electrochemical Properties of Alx FeCoNiCrTi High-Entropy Alloys
Alloys with composition of AlxFeCoNiCrTi(x:molar ratio;x=0.5,1,1.5,2)were designed by using of the strategy of equiatomic ratio… Expand
Is this relevant?
2002
2002
Positron Lifetime Study of Defect Structures in B2 Ordered Co-Al Alloys
The positron lifetimes in the B2 intermetallic compounds Co100−XAlX (X=46.9 to 54.1) water-quenched, air- and furnace-cooled from… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1990
1990
Étude structurale des super-réseaux (Ga1-x Alx As)n1 / (GaAs)n2 au moyen de la microscopie électronique en transmission
 
Is this relevant?